These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 7505332)

  • 1. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
    Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
    J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
    de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
    J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
    de Paulis A; Ciccarelli A; Marinò I; de Crescenzo G; Marinò D; Marone G
    Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antineoplastic bryostatins affect human basophils and mast cells differently.
    Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
    Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
    Marone G; Stellato C; Mastronardi P; Mazzarella B
    Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate.
    Peachell PT; MacGlashan DW; Lichtenstein LM; Schleimer RP
    J Immunol; 1988 Jan; 140(2):571-9. PubMed ID: 2447182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
    Patella V; Casolaro V; Björck L; Marone G
    J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
    Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
    J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
    Patella V; Bouvet JP; Marone G
    J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
    J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.